EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
   3.1.4.53 | Asthma |
29501013 |
(P)/(M)-corinepalensin A, a pair of axially chiral prenylated bicoumarin enantiomers with a rare C-5C-5' linkage from the twigs of Coriaria nepalensis. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 3.1.4.53 | Pulmonary Disease, Chronic Obstructive |
29501013 |
(P)/(M)-corinepalensin A, a pair of axially chiral prenylated bicoumarin enantiomers with a rare C-5C-5' linkage from the twigs of Coriaria nepalensis. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 3.1.4.53 | Dermatitis, Atopic |
28290219 |
2% Crisaborole topical ointment for the treatment of mild-to-moderate atopic dermatitis. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
1
4
0 |
| 3.1.4.53 | Psoriasis |
28290219 |
2% Crisaborole topical ointment for the treatment of mild-to-moderate atopic dermatitis. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
1
4
0 |
| 3.1.4.53 | Dermatitis, Atopic |
28416366 |
2-Year animal carcinogenicity results for crisaborole, a novel phosphodiesterase 4 inhibitor for atopic dermatitis. |
therapeutic application
unassigned |
4
0 |
| 3.1.4.53 | Pulmonary Disease, Chronic Obstructive |
32504994 |
3,4,5-Trihydroxycinnamic acid exerts a protective effect on pulmonary inflammation in an experimental animal model of COPD. |
ongoing research
therapeutic application
unassigned |
3
2
0 |
| 3.1.4.53 | Arthritis, Rheumatoid |
22313294 |
3D-QSAR of novel phosphodiesterase-4 inhibitors by genetic function approximation. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 3.1.4.53 | Asthma |
22313294 |
3D-QSAR of novel phosphodiesterase-4 inhibitors by genetic function approximation. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 3.1.4.53 | Pulmonary Disease, Chronic Obstructive |
22313294 |
3D-QSAR of novel phosphodiesterase-4 inhibitors by genetic function approximation. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 3.1.4.53 | Carcinoma |
11992633 |
7-Benzylamino-6-chloro-2-piperazino-4-pyrrolidino-pteridine, a potent inhibitor of cAMP-specific phosphodiesterase, enhancing nuclear protein binding to the CRE consensus sequence in human tumour cells. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
4
1
0 |
